DE3805459A1 - Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. - Google Patents
Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.Info
- Publication number
- DE3805459A1 DE3805459A1 DE3805459A DE3805459A DE3805459A1 DE 3805459 A1 DE3805459 A1 DE 3805459A1 DE 3805459 A DE3805459 A DE 3805459A DE 3805459 A DE3805459 A DE 3805459A DE 3805459 A1 DE3805459 A1 DE 3805459A1
- Authority
- DE
- Germany
- Prior art keywords
- plasma
- blood
- sterilization
- vitamins
- sterilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fertilizers (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3805459A DE3805459A1 (de) | 1988-02-22 | 1988-02-22 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
ES198989102469T ES2035384T3 (es) | 1988-02-22 | 1989-02-14 | Procedimiento para la esterilizacion de sangre, plasma, derivados de la sangre y del plasma, suspensiones celulares o similares. |
AT89102469T ATE80803T1 (de) | 1988-02-22 | 1989-02-14 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
DE8989102469T DE58902313D1 (de) | 1988-02-22 | 1989-02-14 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
EP89102469A EP0330047B1 (de) | 1988-02-22 | 1989-02-14 | Verfahren zur Sterilisation von Blut, Plasma, Blut- und Plasmaderivaten, Zellsuspensionen oder dgl. |
US07/311,483 US5011695A (en) | 1988-02-22 | 1989-02-16 | Sterilization of blood and its derivatives with vitamins |
JP1040470A JPH025957A (ja) | 1988-02-22 | 1989-02-22 | 血液、血液誘導体、血漿乃至は血漿誘導体の殺菌方法 |
GR920402193T GR3006630T3 (US20040097461A1-20040520-C00035.png) | 1988-02-22 | 1992-12-22 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3805459A DE3805459A1 (de) | 1988-02-22 | 1988-02-22 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3805459A1 true DE3805459A1 (de) | 1989-08-31 |
Family
ID=6347890
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3805459A Withdrawn DE3805459A1 (de) | 1988-02-22 | 1988-02-22 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
DE8989102469T Expired - Lifetime DE58902313D1 (de) | 1988-02-22 | 1989-02-14 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8989102469T Expired - Lifetime DE58902313D1 (de) | 1988-02-22 | 1989-02-14 | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
Country Status (7)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3930510A1 (de) * | 1989-09-13 | 1991-03-21 | Blutspendedienst Dt Rote Kreuz | Verfahren zur inaktivierung von viren in blut und blutprodukten |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242642A (en) * | 1989-11-25 | 1993-09-07 | Seiko Epson Corporation | Method of manufacturing a switch substrate |
JPH03219509A (ja) * | 1989-11-25 | 1991-09-26 | Seiko Epson Corp | スイッチ基板及びスイッチ基板製造方法 |
US5418130A (en) * | 1990-04-16 | 1995-05-23 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
US6187572B1 (en) | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
WO1996014740A1 (en) * | 1992-03-02 | 1996-05-23 | Cerus Corporation | Synthetic media for blood components |
US5288605A (en) * | 1992-03-02 | 1994-02-22 | Steritech, Inc. | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
CA2141803C (en) * | 1992-08-07 | 2003-06-17 | Lily Lin | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US6764693B1 (en) | 1992-12-11 | 2004-07-20 | Amaox, Ltd. | Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
US5741894A (en) * | 1995-09-22 | 1998-04-21 | Baxter International, Inc. | Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
US6524568B2 (en) * | 1998-06-22 | 2003-02-25 | Cytomedix, Inc. | Enriched platelet wound healant |
GB2342046B (en) * | 1998-06-22 | 2004-02-18 | Autologous Wound Therapy Inc | Application for utility patent for improved enriched platelet wound healant |
US7049110B2 (en) * | 1998-07-21 | 2006-05-23 | Gambro, Inc. | Inactivation of West Nile virus and malaria using photosensitizers |
US20070099170A1 (en) * | 1998-07-21 | 2007-05-03 | Navigant Biotechnologies, Inc. | Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US7498156B2 (en) * | 1998-07-21 | 2009-03-03 | Caridianbct Biotechnologies, Llc | Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components |
US20030215784A1 (en) * | 1998-07-21 | 2003-11-20 | Dumont Larry Joe | Method and apparatus for inactivation of biological contaminants using photosensitizers |
US7094378B1 (en) | 2000-06-15 | 2006-08-22 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
TW590780B (en) * | 2000-06-02 | 2004-06-11 | Gambro Inc | Additive solutions containing riboflavin |
US7985588B2 (en) * | 2000-06-02 | 2011-07-26 | Caridianbct Biotechnologies, Llc | Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
US7648699B2 (en) * | 2000-06-02 | 2010-01-19 | Caridianbct Biotechnologies, Llc | Preventing transfusion related complications in a recipient of a blood transfusion |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US6843961B2 (en) * | 2000-06-15 | 2005-01-18 | Gambro, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US6548241B1 (en) | 2000-11-28 | 2003-04-15 | Gambro, Inc. | Storage solution containing photosensitizer for inactivation of biological contaminants |
US20090023130A1 (en) * | 2003-02-28 | 2009-01-22 | Caridianbct Biotechnologies, Llc | Prevention of Transfusion Related Acute Lung Injury Using Riboflavin and Light |
JP4828126B2 (ja) * | 2005-02-03 | 2011-11-30 | 日本メナード化粧品株式会社 | 抗菌剤 |
WO2007038686A2 (en) * | 2005-09-27 | 2007-04-05 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
EP2205285A2 (en) * | 2007-08-01 | 2010-07-14 | CaridianBCT Biotechnologies, LLC | Pathogen inactivation of whole blood |
FR2963240B1 (fr) * | 2010-07-28 | 2013-03-15 | Horus Pharma | Composition a usage topique sans conservateur comprenant de l'acide hyaluronique |
US20220054637A1 (en) * | 2018-11-07 | 2022-02-24 | Terumo Kabushiki Kaisha | Method for producing a blood product |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1556120A (en) * | 1925-10-06 | Method of sterilizing proteins or other colloidal material | ||
US4179338A (en) * | 1977-09-19 | 1979-12-18 | Gordon Maurice R | Microbiological medium suitable for sterilization by ionizing radiation |
JPS5874617A (ja) * | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | 人由来血液凝固第7因子含有水溶液の加熱処理方法 |
US4845074A (en) * | 1982-05-13 | 1989-07-04 | Cedars Sinai Medical Center | Heat treatment of Factor VIII |
US4481189A (en) * | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
AT382078B (de) * | 1983-05-31 | 1987-01-12 | Immuno Ag | Verfahren zur herstellung von praeparationen aus menschlichem blutplasma |
HUT40311A (en) * | 1983-06-03 | 1986-12-28 | Kiskunhalasi Aag | Process for producing protein concentrates, blood-curd and nutriments from blood and its elements |
US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
-
1988
- 1988-02-22 DE DE3805459A patent/DE3805459A1/de not_active Withdrawn
-
1989
- 1989-02-14 ES ES198989102469T patent/ES2035384T3/es not_active Expired - Lifetime
- 1989-02-14 AT AT89102469T patent/ATE80803T1/de not_active IP Right Cessation
- 1989-02-14 EP EP89102469A patent/EP0330047B1/de not_active Expired - Lifetime
- 1989-02-14 DE DE8989102469T patent/DE58902313D1/de not_active Expired - Lifetime
- 1989-02-16 US US07/311,483 patent/US5011695A/en not_active Expired - Fee Related
- 1989-02-22 JP JP1040470A patent/JPH025957A/ja active Pending
-
1992
- 1992-12-22 GR GR920402193T patent/GR3006630T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3930510A1 (de) * | 1989-09-13 | 1991-03-21 | Blutspendedienst Dt Rote Kreuz | Verfahren zur inaktivierung von viren in blut und blutprodukten |
Also Published As
Publication number | Publication date |
---|---|
EP0330047A3 (en) | 1990-12-19 |
JPH025957A (ja) | 1990-01-10 |
ES2035384T3 (es) | 1993-04-16 |
EP0330047A2 (de) | 1989-08-30 |
ATE80803T1 (de) | 1992-10-15 |
EP0330047B1 (de) | 1992-09-23 |
GR3006630T3 (US20040097461A1-20040520-C00035.png) | 1993-06-30 |
DE58902313D1 (de) | 1992-10-29 |
US5011695A (en) | 1991-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3805459A1 (de) | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. | |
DE69432351T2 (de) | Verfahren zum sterilisieren von produkten | |
DE68907124T3 (de) | Verfahren zum Stabilisieren von menschlichen Albuminlösungen und so erhaltene Lösung. | |
DE69635871T2 (de) | Verfahren und Zusammensetzungen zur selektiven Modikation von Nukleinsäuren | |
EP2295086B1 (de) | Verfahren zur Verringerung der viralen und mikrobiellen Belastung von Pankreatin | |
EP0519901B1 (de) | Durch Hitze und/oder Detergens virusinaktiviertes Blutprodukt | |
DE3033932C2 (de) | Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten | |
EP0306778B1 (de) | Verfahren zur Sterilisation von Plasma oder Plasmafraktionen | |
DE69434445T2 (de) | Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt | |
EP0352500A2 (de) | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt. | |
DE29624488U1 (de) | Anlage zur Inaktivierung von in Blutprodukten enthaltenen Kontaminierungen | |
EP2328623B2 (de) | Verfahren zur verringerung der viralen und mikrobiellen belastung feststoffhaltiger aus dem pankreas von tieren gewonnener extrakte | |
EP0720851A2 (de) | Arzneimittel zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten | |
DE3019847A1 (de) | Verfahren zur herstellung von menschlichem interferon und es enthaltende mittel | |
EP1053754B1 (de) | Verfahren zur Inaktivierung von Viren | |
DE202008003806U1 (de) | Extrakt für die Herstellung von pharmazeutischen Therapeutika und dessen Verwendung als Nahrungs- oder Lebensmittel oder Nahrungsergänzungsmittel | |
DE3813464A1 (de) | Verfahren zur waermebehandlung von fibrinogen | |
DE4434538A1 (de) | Verfahren zur Virusinaktivierung in Gegenwart von Polyalkylenglykol sowie die dabei erhaltene pharmazeutische Präparation | |
EP0212040A1 (de) | Verfahren zur Herstellung von Präparationen auf Basis von Blutgerinnungsfaktoren | |
DE2528584A1 (de) | Verfahren zur inaktivierung der virusinfektiositaet unter gleichzeitiger stabilisierung von virusantigenen | |
DE60118175T2 (de) | Methode zur herstellung einer immunotropischen antiviralen zusammensetzung | |
DE69933217T2 (de) | Herstellungsprozess für pharmazeutische Zubereitungen die menschliches Apotransferrin enthalten | |
DD301781B5 (de) | Virussichere humane Transfer-Faktor-Praeparate und Verfahren zu ihrer Herstellung | |
DE102004036079A1 (de) | Verfahren zur Erhöhung von Wirksamkeit und Sicherheit eines zellkulturbasierenden Arzneimittels | |
DE102007044100A1 (de) | Verfahren zur Reduktion der Viren- und Mikroorganismen-Belastung feststoffhaltiger biologischer Extrakte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |